Literature DB >> 6139437

Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man.

Y Mizushima, A Yanagawa, K Hoshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6139437     DOI： 10.1111/j.2042-7158.1983.tb02862.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  15 in total

1.  Study of molecular mechanism of Prostaglandin E1 in inhibiting coronary heart disease.

Authors:  H J Liu; J W Ma; Z Y Qiao; B Xu
Journal:  Mol Biol Rep       Date:  2013-10-22       Impact factor: 2.316

2.  Entrapping efficiency and drug release profile of an oil-in-water (o/w) emulsion formulation using a polydimethylsiloxane-coated glass bead assay.

Authors:  T Minagawa; Y Kohno; T Suwa; A Tsuji
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

Review 3.  Advancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cure.

Authors:  Hee Young Ju; Che Ry Hong; Hee Young Shin
Journal:  Korean J Pediatr       Date:  2014-10-31

Review 4.  The future potential of eicosanoids and their inhibitors in paediatric practice.

Authors:  T Shimizu
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

5.  Determination of the pH-dependent phase distribution of prostaglandin E1 in a lipid emulsion by ultrafiltration.

Authors:  D L Teagarden; B D Anderson; W J Petre
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

6.  Prolonging the in vivo residence time of prostaglandin E(1) with biodegradable nanoparticles.

Authors:  Tsutomu Ishihara; Miyuki Takahashi; Megumu Higaki; Mitsuko Takenaga; Tohru Mizushima; Yutaka Mizushima
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

7.  Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.

Authors:  M Tohyama; A Baba; T Tsuno; K Aonuma; A Komiyama
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

8.  Dehydration kinetics of prostaglandin E1 in a lipid emulsion.

Authors:  D L Teagarden; B D Anderson; W J Petre
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

9.  Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.

Authors:  Tsutomu Ishihara; Miho Takeda; Haruka Sakamoto; Ayumi Kimoto; Chisa Kobayashi; Naoko Takasaki; Kanae Yuki; Ken-ichiro Tanaka; Mitsuko Takenaga; Rie Igarashi; Taishi Maeda; Naoki Yamakawa; Yoshinari Okamoto; Masami Otsuka; Tatsuhiro Ishida; Hiroshi Kiwada; Yutaka Mizushima; Tohru Mizushima
Journal:  Pharm Res       Date:  2009-07-25       Impact factor: 4.200

10.  New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer.

Authors:  Hiroyuki Murota; Yorihisa Kotobuki; Noriko Umegaki; Mamori Tani; Ichiro Katayama
Journal:  Rheumatol Int       Date:  2008-05-07       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.